
浏览全部资源
扫码关注微信
南方医科大学 中医药学院,广州 510515
吴家扬,从事中药制药研究,E-mail:1003940937@qq.com
刁建新,硕士,实验师,从事中西医结合肝病研究,Tel:020-62789397,E-mail:393685483@qq.com
收稿日期:2018-08-22,
网络出版日期:2018-05-12,
纸质出版日期:2019-03-20
移动端阅览
吴家扬, 全景羽, 周燕鑫, 等. 三黄茵赤汤通过调节HMGB1信号通路防治急性小鼠肝损伤[J]. 中国实验方剂学杂志, 2019,25(6):58-64.
Jia-yang WU, Jing-yu QUAN, Yan-xin ZHOU, et al. Effect of Sanhuang Yinchi Decoction in Preventing Acute Liver Injury by HMGB1 Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(6): 58-64.
吴家扬, 全景羽, 周燕鑫, 等. 三黄茵赤汤通过调节HMGB1信号通路防治急性小鼠肝损伤[J]. 中国实验方剂学杂志, 2019,25(6):58-64. DOI: 10.13422/j.cnki.syfjx.20190603.
Jia-yang WU, Jing-yu QUAN, Yan-xin ZHOU, et al. Effect of Sanhuang Yinchi Decoction in Preventing Acute Liver Injury by HMGB1 Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(6): 58-64. DOI: 10.13422/j.cnki.syfjx.20190603.
目的:
2
探究三黄茵赤汤通过调控高迁移率族蛋白B1(HMGB1)信号通路对四氯化碳(CCl
4
)致小鼠急性肝损伤的防治作用及机制。
方法:
2
随机将48只KM小鼠分为正常组,模型组,三黄茵赤汤低、中、高剂量组及促肝细胞生长素组,建立四氯化碳(CCl
4
)诱导小鼠急性肝损伤模型。三黄茵赤汤低、中、高剂量组分别以剂量为16,32,48 g·kg
-1
·d
-1
的药物灌胃,促肝细胞生长素组给予促肝细胞生长素20 mg·kg
-1
·d
-1
腹腔注射。小鼠肝组织切片病理学变化用苏木精-伊红(HE)染色观察;相关酶试剂盒测定小鼠血清中肝功能指标-丙氨酸氨基转移酶(AST)和天冬氨酸氨基转移酶(ALT)的活性;酶联免疫吸附测定(ELISA)测定小鼠血清中白细胞介素6(IL-6)的表达水平;蛋白免疫印迹法(Western blot)检测小鼠组织中HMGB1,天冬氨酸蛋白水解酶-3(Caspase-3),凋亡相关分子B细胞淋巴瘤-2(Bcl-2),Bcl-2相关x蛋白(Bax)和Toll样受体4(TLR4)的蛋白表达情况。
结果:
2
与正常组比较,模型组明显升高血清中AST,ALT(
P
<
0.05)和IL-6的水平(
P
<
0.05)以及增加肝组织中HMGB1,TLR4和Caspase-3表达(
P
<
0.05)并下调Bcl-2/Bax(
P
<
0.05);与模型组比较,三黄茵赤汤各剂量组均能有效减轻小鼠肝脏的病理损害,降低血清中AST,ALT水平和降低IL-6的表达(
P
<
0.05),不同程度降低降低肝组织匀浆中HMGB1,TLR4和Caspase-3蛋白的表达(
P
<
0.05),并提高Bcl-2/Bax(
P
<
0.05),呈剂量依赖性。
结论:
2
三黄茵赤汤可能通过调控HMGB1/TLR4/NF-
κ
B信号通路,减轻细胞炎症反应,抑制细胞凋亡达到防治小鼠急性肝损伤的作用,HMGB1可能成为防治急性肝损伤的新靶点。
Objective:
2
To investigate the effect and mechanism of Sanhuang Yinchi decoction (SHYCD) in preventing carbon tetrachloride (CCl
4
)-induced acute liver injury by regulating high mobility group box1(HMGB1) signaling pathway.
Method:
2
A total of 48 KM mice were randomly divided into blank control group
model group
low
middle and high-dose SHYCD groups and positive control group. The model of acute liver injury induced by CCl
4
in mice was established. The low
middle and high-dose SHYCD groups were intragastrically administered with drugs (16
32
48 g·kg
-1
·d
-1
) respectively
and the positive control group was given cell growth stimulating hormone (20 mg·kg
-1
·d
-1
) through intraperitoneal injection. Pathological changes of mouse liver tissue sections were observed by hematoxylin-eosin staining (HE); relevant enzyme kits were used to determine liver function indexes in mice serum-alanine aminotransferase (AST) and aspartate aminotransferase (ALT); the expression level of interleukin-6 (IL-6) in mouse serum was determined by enzyme-linked immunosorbent assay (ELISA); Western blot was used to detect the expressions of high mobility group box-1(HMGB1)
cysteine aspartic acid protease(Caspase-3)
apoptosis-related molecules B cell lymphoma(Bcl-2)
Bcl-2 associated x protein(Bax)
and Toll-like receptor 4 (TLR4).
Result:
2
Compared with the normal group
the model group significantly increased serum AST
ALT (
P
<
0.05) and IL-6 levels (
P
<
0.05) and expressions of HMGB1
TLR4 and Caspase-3 (P
<
0.05)
and down-regulated Bcl-2/Bax ratio (
P
<
0.05) in liver tissue; compared with the model group
SHYCD can effectively alleviate the pathological damage of liver in mice
reduce serum AST and ALT levels and expressions of IL-6
HMGB1
TLR4 and Caspase-3 protein in liver homogenate (
P
<
0.05)
and increased the ratio of Bcl-2/Bax (
P
<
0.05) in a dose-dependent manner.
Conclusion:
2
SHYCD can prevent liver injury by regulating HMGB1/TLR4/NF-
κ
B signaling pathway
reducing cellular inflammatory response and inhibiting apoptosis
so as to prevent acute liver injury in mice. This indicates that HMGB1 may become a new target to prevent acute liver injury.
吕晓梅 , 马丽杰 . 中药治疗急性肝损伤的研究进展 [J]. 中国新药杂志 , 2016 , 25 ( 2 ): 170 - 174 .
Klune J R , Dhupar R , Cardinal J , et al . HMGB1: endogenous danger signaling [J]. Mol Med , 2008 , 14 ( 7/8 ): 476 - 484 .
YANG H , Tracey K J. Targeting HMGB1 in inflammation [J]. Biochim Biophys Acta , 2010 , 1799 ( 1/2 ): 149 - 156 .
张扬 . 清肝方对D-GalN诱导急性肝衰竭大鼠肝损伤及肝再生的影响及机制研究 [D]. 成都 : 成都中医药大学 , 2012 .
Hreggvidsdottir H S , Lundberg A M , Aveberger A C , et al . High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor [J]. Mol Med , 2012 , 18 : 224 - 230 .
Bianchi M E , Agresti A. HMG proteins: dynamic players in gene regulation and differentiation [J]. Curr Opin Genet Dev , 2005 , 15 ( 5 ): 496 - 506 .
杨运高 , 华何与 , 刘定立 . 三黄茵赤汤治疗重症肝炎32例 [J]. 湖南中医杂志 , 2010 , 26 ( 5 ): 63 - 64 .
刁建新 . 三黄茵赤汤通过APE1/Ref-1抑制p53调控凋亡相关蛋白防治慢加急肝衰竭的研究 [D]. 广州 : 南方医科大学 , 2015 .
李海叶 , 刁建新 , 代欢 , 等 . 三黄茵赤汤对D-氨基半乳糖诱导人胚胎肝细胞系LO2坏死的影响 [J]. 中医杂志 , 2017 , 58 ( 9 ): 782 - 786 .
刁建新 , 马文校 , 刘亚伟 , 等 . 三黄茵赤汤的急性毒性实验研究 [J]. 时珍国医国药 , 2014 , 25 ( 4 ): 778 - 779 .
张毫 , 徐满卿 , 丁舸 . 茵陈蒿汤中茵陈、大黄的核心作用 [J]. 长春中医药大学学报 , 2013 , 29 ( 6 ): 1112 - 1114 .
孙冉 . 大黄的药理作用及临床应用分析 [J]. 首都食品与医药 , 2017 , 24 ( 2 ): 51 - 52 .
李芳芳 . 赤芍降血糖作用研究 [D]. 开封 : 河南大学 , 2015 .
王桂芬 . 中药黄芪的药理作用及临床应用效果观察 [J]. 临床医药文献电子杂志 , 2017 , 4 ( 16 ): 3115 - 3116 .
章村田 . 姜黄药理作用研究进展 [J]. 河南中医 , 2015 , 35 ( 5 ): 1188 - 1190 .
陆小华 , 马骁 , 王建 , 等 . 赤芍的化学成分和药理作用研究进展 [J]. 中草药 , 2015 , 46 ( 4 ): 595 - 602 .
杨以琳 , 魏毅 , 张贵平 , 等 . 白芍总苷对NAFLD大鼠HMGB1,TLR4通路的干预作用 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 14 ): 146 - 151 .
罗爽 , 罗霞 , 刘琦 , 等 . 大黄酸对DSS诱导溃疡性结肠炎小鼠的治疗作用及机制探讨 [J]. 中国实验方剂学杂志 , 2017 , 23 ( 11 ): 109 - 113 .
王亦君 , 冯舒涵 , 程锦堂 , 等 . 大黄蒽醌类化学成分和药理作用研究进展 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 13 ): 227 - 234 .
孙永 , 彭明利 . 姜黄素及其衍生物在肝脏相关疾病中防治作用的研究进展 [J]. 药学学报 , 2014 , 49 ( 11 ): 1483 - 1490 .
陈雪龙 , 齐艳萍 . 四氯化碳急性肝损伤小鼠血清及肝脏组织学变化 [J]. 中国兽医杂志 , 2011 , 47 ( 1 ): 39 - 40 .
Bianchi M E . HMGB1 loves company [J]. J Leukoc Biol , 2009 , 86 ( 3 ): 573 - 576 .
Park J S , Gamboni-Robertson F , HE Q , et al . High mobility group box 1 protein interacts with multiple Toll-like receptors [J]. Am J Physiol Cell Physiol , 2006 , 290 ( 3 ): 917 - 924 .
Ibrahim Z A , Armour C L , Phipps S , et al . RAGE and TLRs: relatives,friends or neighbours? [J]. Mol Immunol , 2013 , 56 ( 4 ): 739 - 744 .
Sims G P , Rowe D C , Rietdijk S T , et al . HMGB1 and RAGE in inflammation and cancer [J]. Annu Rev Immunol , 2010 , 28 : 367 - 388 .
YANG H , Hreggvidsdottir H S , Palmblad K , et al . A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release [J]. Proc Natl Acad Sci USA , 2010 , 107 ( 26 ): 11942 - 11947 .
侯文婧 . HMGB1与肝损伤相关研究进展 [J]. 中国肝脏病杂志:电子版 , 2017 , 9 ( 2 ): 5 - 9 .
LI L , LING Y , HUANG M , et al . Heparin inhibits the inflammatory response induced by LPS and HMGB1 by blocking the binding of HMGB1 to the surface of macrophages [J]. Cytokine , 2015 , 72 ( 1 ): 36 - 42 .
Hardwick J M , Soane L. Multiple functions of BCL-2 family proteins [J]. Cold Spring Harb Perspect Biol , 2013 , 5 ( 2 ): 1 - 22 .
Mcarthur K , Whitehead L W , Heddleston J M , et al . BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis [J]. Science , 2018 , 359 ( 6378 ): 883 - 897 .
唐爱存 , 陈兆霓 , 卢秋玉 , 等 . 葫芦茶苷对肝损伤大鼠肝组织Caspase-3与Caspase-8活性的影响及保肝作用研究 [J]. 中华中医药学刊 , 2017 , 35 ( 3 ): 689 - 692 .
0
浏览量
14
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621